UPDATE - Citi downgrades SenoRx Inc (Nasdaq: SENO) from Buy to Hold. Price target increased from $10 to $11.

Citi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE